Oxygen radical production and severity of the Guillain-Barré syndrome

Journal of Neuroimmunology

Volumn 192, Issue 1-2, 2007, Pages 186-191

  Mossberg, Natalia ^a   Andersen, Oluf ^a   Nilsson, Staffan ^b   Dahlgren, Claes ^c   Hellstrand, Kristoffer ^d   Lindh, Magnus ^d   Svedhem, Åke ^d   Bergström, Tomas ^d   Movitz, Charlotta ^d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Autoimmunity; Guillain Barr syndrome; NADPH oxidase; Phagocytes; Reactive oxygen species; Severity

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE; MALE; PHAGOCYTOSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NADPH OXIDASE; OLIGOPEPTIDES; REACTIVE OXYGEN SPECIES; SEVERITY OF ILLNESS INDEX; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36749075558     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.020     Document Type: Article

References (32)

1. Andrews D.M., Matthews V.B., Sammels L.M., Carrello A.C., and McMinn P.C. The severity of Murray Valley encephalitis in mice is linked to neutrophil infiltration and inducible nitric oxide synthase activity in the central nervous system. J. Virol. 73 (1999) 8781-8790
2. Ang C.W., Jacobs B.C., and Laman J.D. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol. 25 (2004) 61-66
3. Asbury A.K., and Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann. Neurol. 27 (1990) S21-S24 Suppl
4. Asbury A.K., Arnason B.G., and Adams R.D. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 48 (1969) 173-215
5. Babior B.M. Phagocytes and oxidative stress. Am. J. Med. 109 (2000) 33-44
6. Berkow R.L., Wang D., Larrick J.W., Dodson R.W., and Howard T.H. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J. Immunol. 139 (1987) 3783-3791
7. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest., Suppl. 97 (1968) 77-89
8. Bylund J., Karlsson A., Boulay F., and Dahlgren C. Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1. Infect. Immun. 70 (2002) 2908-2914
9. Bylund J., Pellme S., Fu H., Mellqvist U.H., Hellstrand K., Karlsson A., and Dahlgren C. Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils. BMC Cell Biol. 5 (2004) 21
10. Carroll M. Innate immunity in the etiopathology of autoimmunity. Nat. Immunol. 2 (2001) 1089-1090
11. Dahlgren C., and Karlsson A. Respiratory burst in human neutrophils. J. Immunol. Methods 232 (1999) 3-14
12. Etzioni A. Immune deficiency and autoimmunity. Autoimmun. Rev. 2 (2003) 364-369
13. Fu H., Karlsson J., Bylund J., Movitz C., Karlsson A., and Dahlgren C. Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79 (2006) 247-256
14. Gelderman K.A., Hultqvist M., Holmberg J., Olofsson P., and Holmdahl R. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12831-12836
15. Geleijns K., Roos A., Houwing-Duistermaat J.J., van Rijs W., Tio-Gillen A.P., Laman J.D., van Doorn P.A., and Jacobs B.C. Mannose-binding lectin contributes to the severity of Guillain-Barre syndrome. J. Immunol. 177 (2006) 4211-4217
16. Hadden R.D., Karch H., Hartung H.P., Zielasek J., Weissbrich B., Schubert J., Weishaupt A., Cornblath D.R., Swan A.V., Hughes R.A., and Toyka K.V. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 56 (2001) 758-765
17. Hultqvist M., Olofsson P., Holmberg J., Backstrom B.T., Tordsson J., and Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 12646-12651
18. Hultqvist M., Olofsson P., Gelderman K.A., Holmberg J., and Holmdahl R. A new arthritis therapy with oxidative burst inducers. PLoS Med. 3 (2006) e348
19. Hultqvist M., Backlund J., Bauer K., Gelderman K.A., and Holmdahl R. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J. Immunol. 179 (2007) 1431-1437
20. Klebanoff S.J. Myeloperoxidase. Proc. Assoc. Am. Physicians 111 (1999) 383-389
21. Klebanoff S.J., and Coombs R.W. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system. J. Clin. Invest. 89 (1992) 2014-2017
22. Kleyweg R.P., van der Meche F.G., and Schmitz P.I. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve 14 (1991) 1103-1109
23. Lundqvist H., and Dahlgren C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic. Biol. Med. 20 (1996) 785-792
24. Metcalf J.A., Gallin J.I., Nauseef W.M., and Root R.K. Laboratory Manual of Neutrophil Function (1986)
25. Minohara M., Matsuoka T., Li W., Osoegawa M., Ishizu T., Ohyagi Y., and Kira J. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J. Neuroimmunol. 178 (2006) 156-160
26. Olofsson P., Holmberg J., Tordsson J., Lu S., Akerstrom B., and Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat. Genet. 33 (2003) 25-32
27. Park E., Jia J., Quinn M.R., and Schuller-Levis G. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin. Immunol. 102 (2002) 179-184
28. Ramsaransing G., Teelken A., Prokopenko V.M., Arutjunyan A.V., and De Keyser J. Low leucocyte myeloperoxidase activity in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 74 (2003) 953-955
29. Svedhem A., Gunnarsson H., and Kaijser B. Diffusion-in-gel enzyme-linked immunosorbent assay for routine detection of IgG and IgM antibodies to Campylobacter jejuni. J. Infect. Dis. 148 (1983) 82-92
30. van Heel D.A., Ghosh S., Hunt K.A., Mathew C.G., Forbes A., Jewell D.P., and Playford R.J. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut. 54 (2005) 1553-1557
31. Visser L.H., Schmitz P.I., Meulstee J., van Doorn P.A., and van der Meche F.G. Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barre Study Group. Neurology 53 (1999) 598-604
32. Wolfson M., McPhail L.C., Nasrallah V.N., and Snyderman R. Phorbol myristate acetate mediates redistribution of protein kinase C in human neutrophils: potential role in the activation of the respiratory burst enzyme. J. Immunol. 135 (1985) 2057-2062